Skip to content

Cross-over Comparison of the V60 System to Other Bi-Level Noninvasive Ventilators

Cross-over Comparison of the V60 System to Other Bi-Level Noninvasive Ventilators for Pediatric Patients With Respiratory Failure or Respiratory Insufficiency

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00817804
Enrollment
3
Registered
2009-01-06
Start date
2009-01-31
Completion date
2009-03-31
Last updated
2009-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Failure, Respiratory Insufficiency

Keywords

noninvasive ventilation

Brief summary

The purpose of this study is to compare a new noninvasive ventilator to existing ventilators already used for patient care.

Detailed description

This study compares the Respironics California V60 Mask ventilator to conventional noninvasive ventilators in a cross-over study with the patient as his/her own control.

Interventions

DEVICEUse of the V60 Mask Ventilator

The V60 Mask Ventilator used to provide noninvasive ventilation. It is compared to the patient's conventional ventilator in a cross-over study. The ventilator settings can range from CPAP to Pressure Support ventilation with values of IPAP and EPAP to match the conventional ventilation on which the patient had been placed.

Sponsors

Respironics, California, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Age \> 7 years and \< 18 years * Weight \> 20 kg (44 lbs) * Respiratory failure or respiratory insufficiency * Ability to cooperate with the investigators * Designated adult able to provide Informed Consent

Exclusion criteria

* An endotracheal tube or tracheostomy in place * Hemodynamically instability * Prolonged apnea * Inability to maintain the airway * A recent history of cardiac and or respiratory arrest * Acute hemorrhage * Multiple organ system failure * Undrained pneumothorax * High risk for aspiration * Metastatic or terminal cancer * Do-not-resuscitate orders * Inability to clear respiratory secretions * Inability to fit a mask * Facial surgery, trauma, or deformity * Upper gastrointestinal or airway surgery * Pregnancy * Refractory delirium * PaO2 \< 50 mmHg on present settings * Designee unable or unwilling to provide Informed Consent

Design outcomes

Primary

MeasureTime frameDescription
Breathing Comfort30 minutesComfort on visual analog scale 0 - 100, 0 is best

Secondary

MeasureTime frameDescription
Saturation of Arterial Oxygen30 minutes
Respiratory Rate30 minutesBreathing rate in breaths per minute
Minute Ventilation30 minutesLiters per minute that the patient breathes
Heart Rate30 minutesBeats per minute that the patient's heart is beating
Blood Pressure30 minutesSystolic and diastolic blood pressure

Countries

Canada

Participant flow

Recruitment details

Hospitalized adult patients enrolled between Jan 17 and Mar 3, 2009.

Pre-assignment details

Excluded if did not meet inclusion or did meet exclusion criteria.

Participants by arm

ArmCount
V60 First
Experimental Study device (used as the experimental device) first in the cross-over study
1
Conventional First
Experimental Study device (used as the experimental device) second in the cross-over study
2
Total3

Baseline characteristics

CharacteristicConventional FirstV60 FirstTotal
Age, Categorical
<=18 years
2 Participants1 Participants3 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age Continuous11.5 years
STANDARD_DEVIATION 4.9
16.0 years
STANDARD_DEVIATION 0
13.0 years
STANDARD_DEVIATION 4.4
Region of Enrollment
Canada
2 participants1 participants3 participants
Sex: Female, Male
Female
1 Participants0 Participants1 Participants
Sex: Female, Male
Male
1 Participants1 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / —0 / —
serious
Total, serious adverse events
0 / —0 / —

Outcome results

Primary

Breathing Comfort

Comfort on visual analog scale 0 - 100, 0 is best

Time frame: 30 minutes

Population: Analysis was per protocol

ArmMeasureGroupValue (MEAN)Dispersion
V60 FirstBreathing ComfortV6010 visual analog scaleStandard Error 0
V60 FirstBreathing ComfortConventional33.3 visual analog scaleStandard Error 0
Conventional FirstBreathing ComfortV6040 visual analog scaleStandard Error 14.1
Conventional FirstBreathing ComfortConventional45 visual analog scaleStandard Error 7.1
Secondary

Blood Pressure

Systolic and diastolic blood pressure

Time frame: 30 minutes

Secondary

Heart Rate

Beats per minute that the patient's heart is beating

Time frame: 30 minutes

Secondary

Minute Ventilation

Liters per minute that the patient breathes

Time frame: 30 minutes

Secondary

Respiratory Rate

Breathing rate in breaths per minute

Time frame: 30 minutes

Secondary

Saturation of Arterial Oxygen

Time frame: 30 minutes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026